Status:
COMPLETED
Positron Emission Tomography in Prostate Cancer
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Prostate Cancer
Eligibility:
MALE
Phase:
NA
Brief Summary
RATIONALE: Diagnostic procedures, such as positron emission tomography using carbon-11 acetate, may help find metastases from prostate cancer and may help predict whether prostate cancer will come bac...
Detailed Description
The overall goal of this project is determination of the role of PET in patients with newly diagnosed medium- and high-risk prostate cancer in whom the standard clinical and imaging workup is negative...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Newly diagnosed prostate cancer
- Has completed conventional staging examinations, including biopsy with Gleason score, CT scan of the abdomen and pelvis, and whole-body bone scintigraphy AND conventional staging examinations negative
- Candidate for curative radical prostatectomy OR curative radiotherapy OR staging lymphadenectomy prior to surgery
- Deemed to be at medium or high risk for recurrence after initial curative treatment, as defined by 1 of the following criteria:
- Gleason score 7 AND prostate-specific antigen (PSA) 10-20 ng/mL
- Gleason score ≥ 8 AND PSA \< 10 ng/mL
- Gleason score ≥ 8 AND PSA \> 10 ng/mL
- Any Gleason score AND PSA \> 20 ng/mL
- Exclusion Therapy:
- Not a candidate for treatment by surgery or radiation therapy with curative intent
- Inability to give informed consent
- Patients with other invasive malignancies, with the exception of non-melanoma skin cancer, who had (or have) any evidence of other cancer present within the last 5 years
Exclusion
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
179 Patients enrolled
Trial Details
Trial ID
NCT00121212
Start Date
July 1 2003
End Date
October 1 2015
Last Update
October 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
St Louis, Missouri, United States, 63110